Exploratory treatment trials in multiple sclerosis using MRI: sample size calculations for relapsing-remitting and secondary progressive subgroups using placebo controlled parallel groups (Q36317642)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Exploratory treatment trials in multiple sclerosis using MRI: sample size calculations for relapsing-remitting and secondary progressive subgroups using placebo controlled parallel groups	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

13 August 2017

Exploratory treatment trials in multiple sclerosis using MRI: sample size calculations for relapsing-remitting and secondary progressive subgroups using placebo controlled parallel groups (English)

1 reference

Europe PubMed Central

13 August 2017

0 references

multiple sclerosis

0 references

author name string

Tubridy N

1

1 reference

Europe PubMed Central

13 August 2017

Ader HJ

2

1 reference

Europe PubMed Central

13 August 2017

Barkhof F

3

1 reference

Europe PubMed Central

13 August 2017

Thompson AJ

4

1 reference

Europe PubMed Central

13 August 2017

Miller DH

5

1 reference

Europe PubMed Central

13 August 2017

language of work or name

0 references

publication date

1 January 1998

1 reference

Europe PubMed Central

13 August 2017

Journal of Neurology, Neurosurgery and Psychiatry

1 reference

Europe PubMed Central

13 August 2017

64

1 reference

Europe PubMed Central

13 August 2017

1

1 reference

Europe PubMed Central

13 August 2017

50-55

1 reference

Europe PubMed Central

13 August 2017

describes a project that uses

magnetic resonance imaging

1 reference

based on heuristic

inferred from title

Statistical data analysis in the computer age.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2169905

30 September 2017

Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2169905

30 September 2017

Clinical outcomes assessment in multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2169905

30 September 2017

Defining the clinical course of multiple sclerosis: Results of an international survey

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2169905

30 September 2017

Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2169905

30 September 2017

MRI dynamics of brain and spinal cord in progressive multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2169905

30 September 2017

Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2169905

30 September 2017

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2169905

30 September 2017

High dose steroids in acute relapses of multiple sclerosis: MRI evidence for a possible mechanism of therapeutic effect

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2169905

30 September 2017

Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2169905

29 June 2018

Interrater variability with the Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trial. The Canadian Cooperation MS Study Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2169905

29 June 2018

Using gadolinium-enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2169905

29 June 2018

Outcomes assessment in multiple sclerosis clinical trials: a critical analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2169905

22 September 2018

Serial gadolinium-enhanced MRI of the brain and spinal cord in early relapsing-remitting multiple sclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2169905

22 September 2018

Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesions.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2169905

22 September 2018

Magnetic resonance imaging in monitoring the treatment of multiple sclerosis patients: statistical power of parallel-groups and crossover designs.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2169905

22 September 2018

Limited duration of the effect of methylprednisolone on changes on MRI in multiple sclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2169905

22 September 2018

Blood-brain barrier disruption on contrast-enhanced MRI in patients with mild relapsing-remitting multiple sclerosis: relationship to course, gender, and age.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2169905

22 September 2018

Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2169905

22 September 2018

Multiple sclerosis: A serial study using MRI in relapsing patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/9436727

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serial magnetic resonance scanning in multiple sclerosis: a second prospective study in relapsing patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/9436727

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Major differences in the dynamics of primary and secondary progressive multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9436727

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multiple sclerosis: serial study of gadolinium-enhanced MR imaging

1 reference

https://pubmed.ncbi.nlm.nih.gov/9436727

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serial gadolinium-enhanced MRI in relapsing/remitting multiple sclerosis of varying disease duration

1 reference

https://pubmed.ncbi.nlm.nih.gov/9436727

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of secondary progressive multiple sclerosis with the immunomodulator linomide: a double-blind, placebo-controlled pilot study with monthly magnetic resonance imaging evaluation

1 reference

https://pubmed.ncbi.nlm.nih.gov/9436727

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/JNNP.64.1.50

1 reference

Europe PubMed Central

13 August 2017

1 reference

Europe PubMed Central

13 August 2017

1 reference

Europe PubMed Central

13 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36317642&oldid=1877328592"